Singapore-based alternative protein maker Growthwell has raised $15.9 million in a Series A round from state investor Temasek and French private equity firm Creadev, according to Accounting and Corporate Regulatory Authority (ACRA) regulatory filings accessed by DealStreetAsia – DATA VANTAGE.
ACRA filings only reflect the equity funding received so far by a company. The overall funding round could be larger and have other components such as debt.
